Search - tctmd.com

Displaying 361 - 380 of 383

Sort: Relevancy | Date

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

Presentation TCT 2012

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

Presenter: Javier Escaned

October 25, 2012

Presentation TCT 2012

ESC Guidelines: No Need for Appropriate Use Criteria for PCI: A European Perspective

Presenter: Kurt Huber

October 24, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

The 2012 ESC Mitral Valve Guidelines: What's New, and How Should They Affect Practice?

Presenter: Francesco Maisano

October 23, 2012

Presentation TCT 2012

MitraClip Registries: ACCESS-EU, GERMAN Registry, ESC Registry, High-Risk Registry, and REALISM: What Have We Learned Recently?

Presenter: Francesco Maisano

October 23, 2012

Presentation

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Presenter: 62744|Gregg Stone

September 18, 2012

Presentation ESC 2012

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Presenter: Willem Dewilde

August 28, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

Presentation ESC 2012

FFR-guided PCI versus Medical Therapy for Stable Cornary Disease

Presenter: Bernard De Bruyne

August 28, 2012

Presentation ESC 2012

Early Experience With the JenaValve™ Transapical Aortic Valve Implantation System

Presenter: Markus Ferrari

August 28, 2012

Presentation ESC 2012

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed Tomographic Angiography: The DeFACTO Study

Presenter: James K. Min

August 28, 2012

Presentation ESC 2012

Rivaroxaban in Patients following a ST-Elevation Myocardial Infarction

Presenter: Jessica L. Mega

August 27, 2012

Presentation ESC 2012

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

Presenter: 168042|Holger Thiele

August 27, 2012

Presentation ESC 2012

Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial

Presenter: William Wijns

August 27, 2012

Presentation ESC 2012

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Presenter: Tudor C. Poerner

August 27, 2012

Presentation ESC 2012

ACCESS-EUROPE Phase I - A Post Market Study of the MitraClip System for the Treatment of Significant Mitral Regurgitation in Europe: Analysis of Outcomes at 1 Year

Presenter: Wolfgang Schillinger

August 27, 2012

Presentation ESC 2012

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Presenter: 205474|Benjamin Scirica

August 26, 2012

Advertisement

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

ESC Guidelines: No Need for Appropriate Use Criteria for PCI: A European Perspective

Synthesis of the New ESC LAA Closure Guidelines

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

The 2012 ESC Mitral Valve Guidelines: What's New, and How Should They Affect Practice?

MitraClip Registries: ACCESS-EU, GERMAN Registry, ESC Registry, High-Risk Registry, and REALISM: What Have We Learned Recently?

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

FFR-guided PCI versus Medical Therapy for Stable Cornary Disease

Early Experience With the JenaValve™ Transapical Aortic Valve Implantation System

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed Tomographic Angiography: The DeFACTO Study

Rivaroxaban in Patients following a ST-Elevation Myocardial Infarction

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

ACCESS-EUROPE Phase I - A Post Market Study of the MitraClip System for the Treatment of Significant Mitral Regurgitation in Europe: Analysis of Outcomes at 1 Year

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content